PMID- 15653932 OWN - NLM STAT- MEDLINE DCOM- 20050428 LR - 20180815 IS - 1044-1549 (Print) IS - 1044-1549 (Linking) VI - 32 IP - 4 DP - 2005 Apr TI - Tumor necrosis factor-alpha induces transforming growth factor-beta1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway. PG - 342-9 AB - Increased expression of transforming growth factor (TGF)-beta(1) and tumor necrosis factor (TNF)-alpha are thought to play important roles in the development of pulmonary fibrosis. We recently reported that TNF-alpha upregulates TGF-beta(1) expression in primary mouse lung fibroblasts (MLFs), a key cell population in fibrogenesis. In the present study, we have investigated signal transduction pathways involved in TNF-alpha upregulation of TGF-beta(1) in both primary MLFs and the Swiss 3T3 fibroblast cell line. Treatment of fibroblasts with TNF-alpha resulted in a significant increase in TGF-beta(1) protein as measured by ELISA. The increase in protein was preceded by a 200-400% increase in TGF-beta(1) mRNA detected by quantitative, real-time, reverse transcriptase-polymerase chain reaction. Western blot analysis showed that TNF-alpha activated the extracellular signal-regulated kinase (ERK), and inhibitors of the ERK-specific mitogen-activated protein kinase pathway (PD98059 or U0126) blocked TNF-alpha induction of TGF-beta(1) mRNA and protein. mRNA stability experiments showed that TNF-alpha increased the half-life of TGF-beta(1) mRNA to more than 24 h compared with approximately 15 h in unstimulated cells. Expression of constitutively active MEK1 that selectively phosphorylates ERK was sufficient for TGF-beta(1) mRNA stabilization in Swiss 3T3 fibroblasts. These results indicate that TNF-alpha activates the ERK-specific mitogen-activated protein kinase pathway leading to increased TGF-beta(1) production in fibroblasts, primarily via a post-transcriptional mechanism that involves stabilization of the TGF-beta(1) transcript. FAU - Sullivan, Deborah E AU - Sullivan DE AD - Department of Pathology and Laboratory Medicine, Lung Biology Program, Tulane University Health Sciences Center, 1430 Tulane Avenue, New Orleans, LA 70112, USA. dsulliva@tulane.edu FAU - Ferris, MaryBeth AU - Ferris M FAU - Pociask, Derek AU - Pociask D FAU - Brody, Arnold R AU - Brody AR LA - eng GR - ES06766/ES/NIEHS NIH HHS/United States GR - HL60532/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. DEP - 20050114 PL - United States TA - Am J Respir Cell Mol Biol JT - American journal of respiratory cell and molecular biology JID - 8917225 RN - 0 (Butadienes) RN - 0 (DNA, Complementary) RN - 0 (Enzyme Inhibitors) RN - 0 (Flavonoids) RN - 0 (Nitriles) RN - 0 (RNA, Messenger) RN - 0 (Recombinant Proteins) RN - 0 (Tgfb1 protein, mouse) RN - 0 (Transforming Growth Factor beta) RN - 0 (Transforming Growth Factor beta1) RN - 0 (Tumor Necrosis Factor-alpha) RN - 0 (U 0126) RN - SJE1IO5E3I (2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one) SB - IM MH - Animals MH - Base Sequence MH - Butadienes/pharmacology MH - Cells, Cultured MH - DNA, Complementary/genetics MH - Enzyme Inhibitors/pharmacology MH - Fibroblasts/drug effects/metabolism MH - Flavonoids/pharmacology MH - Gene Expression/drug effects MH - Lung/*drug effects/*metabolism MH - MAP Kinase Signaling System/drug effects MH - Mice MH - Nitriles/pharmacology MH - RNA Stability/drug effects MH - RNA, Messenger/genetics/metabolism MH - Recombinant Proteins/pharmacology MH - Swiss 3T3 Cells MH - Transforming Growth Factor beta/*biosynthesis/*genetics MH - Transforming Growth Factor beta1 MH - Tumor Necrosis Factor-alpha/*pharmacology EDAT- 2005/01/18 09:00 MHDA- 2005/04/29 09:00 CRDT- 2005/01/18 09:00 PHST- 2005/01/18 09:00 [pubmed] PHST- 2005/04/29 09:00 [medline] PHST- 2005/01/18 09:00 [entrez] AID - 2004-0288OC [pii] AID - 10.1165/rcmb.2004-0288OC [doi] PST - ppublish SO - Am J Respir Cell Mol Biol. 2005 Apr;32(4):342-9. doi: 10.1165/rcmb.2004-0288OC. Epub 2005 Jan 14.